Literature DB >> 11191109

The hTERTalpha splice variant is a dominant negative inhibitor of telomerase activity.

L M Colgin1, C Wilkinson, A Englezou, A Kilian, M O Robinson, R R Reddel.   

Abstract

The telomerase catalytic subunit (hTERT) is an essential component of the holoenzyme complex that adds telomeric repeats to the ends of human chromosomes. Maintenance of telomeres by telomerase or another mechanism is required for cell immortalization, and loss of telomeric DNA has been proposed as a trigger for cellular senescence. Available evidence suggests that regulation of telomerase activity primarily depends on transcriptional control of hTERT. However, several human tissues as well as some normal cell strains have been shown to express low levels of hTERT mRNA even though they lack telomerase activity. We have previously identified six splice variants of hTERT, including a "deletion" variant (hTERTalpha) that is missing conserved residues from the catalytic core of the protein. Several of the deletion variants have been detected in normal and developing human tissues. We now show that hTERTalpha inhibits endogenous telomerase activity, which results in telomere shortening and chromosome end-to-end fusions. Telomerase inhibition induced a senescence-like state in HT1080 cells and apoptosis in a jejunal fibroblast cell line. These results suggest a possible role for hTERT splice variants in the regulation of telomerase activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11191109      PMCID: PMC1507985          DOI: 10.1038/sj.neo.7900112

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  30 in total

1.  Up-regulation of telomerase in human B lymphocytes occurs independently of cellular proliferation and with expression of the telomerase catalytic subunit.

Authors:  B T Hu; R A Insel
Journal:  Eur J Immunol       Date:  1999-11       Impact factor: 5.532

2.  Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium.

Authors:  G A Ulaner; J F Hu; T H Vu; H Oruganti; L C Giudice; A R Hoffman
Journal:  Int J Cancer       Date:  2000-02-01       Impact factor: 7.396

Review 3.  Telomere loss: mitotic clock or genetic time bomb?

Authors:  C B Harley
Journal:  Mutat Res       Date:  1991 Mar-Nov       Impact factor: 2.433

4.  SV40-transformed human cells in crisis exhibit changes that occur in normal cellular senescence.

Authors:  I Rubelj; O M Pereira-Smith
Journal:  Exp Cell Res       Date:  1994-03       Impact factor: 3.905

5.  Inhibition of telomerase limits the growth of human cancer cells.

Authors:  W C Hahn; S A Stewart; M W Brooks; S G York; E Eaton; A Kurachi; R L Beijersbergen; J H Knoll; M Meyerson; R A Weinberg
Journal:  Nat Med       Date:  1999-10       Impact factor: 53.440

6.  [Principle of marginotomy in template synthesis of polynucleotides].

Authors:  A M Olovnikov
Journal:  Dokl Akad Nauk SSSR       Date:  1971

7.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

Authors:  G P Dimri; X Lee; G Basile; M Acosta; G Scott; C Roskelley; E E Medrano; M Linskens; I Rubelj; O Pereira-Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

8.  Specific association of human telomerase activity with immortal cells and cancer.

Authors:  N W Kim; M A Piatyszek; K R Prowse; C B Harley; M D West; P L Ho; G M Coviello; W E Wright; S L Weinrich; J W Shay
Journal:  Science       Date:  1994-12-23       Impact factor: 47.728

9.  Lethality induced by a single site-specific double-strand break in a dispensable yeast plasmid.

Authors:  C B Bennett; A L Lewis; K K Baldwin; M A Resnick
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-15       Impact factor: 11.205

10.  Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity.

Authors:  C M Counter; A A Avilion; C E LeFeuvre; N G Stewart; C W Greider; C B Harley; S Bacchetti
Journal:  EMBO J       Date:  1992-05       Impact factor: 11.598

View more
  70 in total

Review 1.  Natural and pharmacological regulation of telomerase.

Authors:  Jean-Louis Mergny; Jean-François Riou; Patrick Mailliet; Marie-Paule Teulade-Fichou; Eric Gilson
Journal:  Nucleic Acids Res       Date:  2002-02-15       Impact factor: 16.971

2.  Coexistence of alternative lengthening of telomeres and telomerase in hTERT-transfected GM847 cells.

Authors:  K Perrem; L M Colgin; A A Neumann; T R Yeager; R R Reddel
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

Review 3.  Tiptoeing to chromosome tips: facts, promises and perils of today's human telomere biology.

Authors:  J Fajkus; M Simícková; J Maláska
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2002-04-29       Impact factor: 6.237

Review 4.  The role of telomeres and telomerase reverse transcriptase isoforms in pluripotency induction and maintenance.

Authors:  Jonathan H Teichroeb; Joohwan Kim; Dean H Betts
Journal:  RNA Biol       Date:  2016-01-19       Impact factor: 4.652

5.  Vertebrate POT1 restricts G-overhang length and prevents activation of a telomeric DNA damage checkpoint but is dispensable for overhang protection.

Authors:  Dmitri Churikov; Chao Wei; Carolyn M Price
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

6.  Function, replication and structure of the mammalian telomere.

Authors:  Dominique Broccoli
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

7.  Colony forming unit endothelial cells do not exhibit telomerase alternative splicing variants and activity.

Authors:  Armin Attar; Mohsen Khosravi Maharlooi; Sara Khoshkhou; Ahmad Hosseini; Mansoureh Jaberipour; Arman Dehghan; Ahmad Monabati
Journal:  Iran Biomed J       Date:  2013

8.  Differentiating alternative splice variant patterns of human telomerase reverse transcriptase in thyroid neoplasms.

Authors:  Yongchun Wang; Jeanne Kowalski; Hua-Ling Tsai; Radharani Marik; Nijaguna Prasad; Helina Somervell; Pang-Kuo Lo; Lauren E Sangenario; Lars Dyrskjot; Torben F Orntoft; William H Westra; Alan K Meeker; James R Eshleman; Christopher B Umbricht; Martha A Zeiger
Journal:  Thyroid       Date:  2008-10       Impact factor: 6.568

Review 9.  Human telomerase and its regulation.

Authors:  Yu-Sheng Cong; Woodring E Wright; Jerry W Shay
Journal:  Microbiol Mol Biol Rev       Date:  2002-09       Impact factor: 11.056

10.  Alternatively spliced telomerase reverse transcriptase variants lacking telomerase activity stimulate cell proliferation.

Authors:  Radmila Hrdlicková; Jirí Nehyba; Henry R Bose
Journal:  Mol Cell Biol       Date:  2012-08-20       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.